Cold & Cough Remedies (Pharmacies) - New Zealand

Revenue in the Cold & Cough Remedies market is projected to reach US$28.62m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.82%, resulting in a market volume of US$39.80m by 2029.
In global comparison, most revenue will be generated China (US$7.83bn in 2024).
In relation to total population figures, per person revenues of US$5.43 are generated in 2024.

Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies (Pharmacies) market in New Zealand is experiencing steady growth due to changing customer preferences and underlying macroeconomic factors. Customer preferences in the Cold & Cough Remedies (Pharmacies) market in New Zealand are shifting towards natural and herbal remedies. This trend is driven by increasing consumer awareness about the potential side effects of traditional over-the-counter medications. Customers are seeking products that are perceived to be safer and have fewer adverse effects on their health. As a result, there is a growing demand for natural and herbal remedies in the market. Another customer preference that is driving the growth of the Cold & Cough Remedies (Pharmacies) market in New Zealand is convenience. Customers are looking for products that are easily accessible and can be purchased without a prescription. Pharmacies are capitalizing on this trend by offering a wide range of cold and cough remedies that can be purchased over the counter. This convenience factor is attracting more customers to pharmacies for their cold and cough remedies needs. In addition to changing customer preferences, there are several local special circumstances that are contributing to the growth of the Cold & Cough Remedies (Pharmacies) market in New Zealand. The country has a high prevalence of respiratory illnesses, such as asthma and allergies, which increases the demand for cold and cough remedies. The cold and damp climate in certain regions of New Zealand also contributes to the occurrence of cold and cough symptoms, further driving the demand for remedies. Furthermore, the underlying macroeconomic factors in New Zealand are also playing a role in the growth of the Cold & Cough Remedies (Pharmacies) market. The country has a stable economy with a growing middle class population. This population segment has higher disposable income and is willing to spend on healthcare products, including cold and cough remedies. The government's focus on promoting and improving healthcare infrastructure also contributes to the growth of the market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in New Zealand is experiencing growth due to changing customer preferences towards natural and herbal remedies, as well as the convenience factor offered by pharmacies. Local special circumstances, such as the high prevalence of respiratory illnesses and the cold climate, further drive the demand for remedies. The underlying macroeconomic factors, including a stable economy and government support for healthcare, also contribute to the growth of the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.